Stifel Nicolaus Reaffirms Buy Rating for Agilent Technologies (NYSE:A)

Stifel Nicolaus restated their buy rating on shares of Agilent Technologies (NYSE:A – Free Report) in a research note published on Monday morning, Stock Target Advisor reports. Stifel Nicolaus currently has a $151.00 target price on the medical research company’s stock. A number of other brokerages have also recently commented on A. TD Cowen raised […]

Leave a Reply

Your email address will not be published.

Previous post Rezolute (NASDAQ:RZLT) Research Coverage Started at Guggenheim
Next post Repligen (NASDAQ:RGEN) Earns Overweight Rating from Analysts at Wells Fargo & Company